A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled, double-blind, multicenter, randomized study for preliminary
evaluation of the efficacy and safety of combining bevacizumab with cisplatin (or
carboplatin) and etoposide in patients with previously untreated extensive-stage small cell
lung cancer (SCLC).